CFTR is a negative regulator of NFκB mediated innate immune response

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Vij, Neeraj ^a   Mazur, Steven ^a   Zeitlin, Pamela L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CFTR 172 INHIBITOR; CHLORIDE CHANNEL BLOCKING AGENT; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LUCIFERASE; PROTEIN INHIBITOR; PSEUDOMONAS AERUGINOSA LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

AIRWAY EPITHELIUM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL FUNCTION; CELL SURFACE; CELLULAR DISTRIBUTION; CFBE41O- CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IN VIVO STUDY; INNATE IMMUNITY; LIPID RAFT; MOLECULAR STABILITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SURVIVAL; WILD TYPE;

EID: 84864288310     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004664     Document Type: Article

References (43)

1. Rowe SM, Miller S, Sorscher EJ (2005) Cystic fibrosis. N Engl J Med 352: 1992-2001.
2. Thibodeau PH, Brautigam CA, Machius M, Thomas PJ (2005) Side chain and backbone contributions of Phe508 to CFTR folding. Nat Struct Mol Biol 12: 10-16.
3. Zaman MM, Gelrud A, Junaidi O, Regan MM, Warny M, et al. (2004) Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered. Clin Diagn Lab Immunol 11: 819-824.
4. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, et al. (1987) Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci U S A 84: 9233-9237.
5. Nakamura H, Yoshimura K, McElvaney NG, Crystal RG (1992) Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest 89: 1478-1484.
6. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, et al. (1993) Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341: 643-647.
7. Marini M, Vittori E, Hollemborg J, Mattoli S (1992) Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 89: 1001-1009.
8. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP 3rd, et al. (1990) Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest 86: 1945-1953.
9. Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, et al. (1995) Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. Bmj 310: 1571-1572.
10. Birrer P, McElvaney NG, Rudeberg A, Sommer CW, Liechti-Gallati S, et al. (1994) Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 150: 207-213.
11. Konstan MW, Hilliard KA, Norvell TM, Berger M (1994) Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 150: 448-454.
12. DiMango E, Zar HJ, Bryan R, Prince A (1995) Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 96: 2204-2210.
13. Massion PP, Inoue H, Richman-Eisenstat J, Grunberger D, Jorens PG, et al. (1994) Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J Clin Invest 93: 26-32.
14. Rubin BK (2007) CFTR is a modulator of airway inflammation. Am J Physiol Lung Cell Mol Physiol 292: L381-382.
15. Rubin BK (2003) A scientific koan: what is the cause of cystic fibrosis? Chest 123: 1792-1793.
16. Machen TE (2006) Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol Cell Physiol 291: C218-230.
17. Tseng J, Do J, Widdicombe JH, Machen TE (2006) Innate immune responses of human tracheal epithelium to Pseudomonas aeruginosa flagellin, TNF-alpha, and IL-1beta. Am J Physiol Cell Physiol 290: C678-690.
18. Vij N, Amoako MO, Mazur S, Zeitlin PL (2008) CHOP transcription factor mediates IL-8 signaling in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol 38: 176-184.
19. Vij N, Fang S, Zeitlin PL (2006) Selective Inhibition of Endoplasmic Reticulumassociated Degradation Rescues {Delta}F508-Cystic Fibrosis Transmembrane Regulator and Suppresses Interleukin-8 Levels: THERAPEUTIC IMPLICATIONS. J Biol Chem 281: 17369-17378.
20. Perez A, Issler AC, Cotton CU, Kelley TJ, Verkman AS, et al. (2007) CFTR inhibition mimics the cystic fibrosis inflammatory profile. Am J Physiol Lung Cell Mol Physiol 292: L383-395.
21. DiMango E, Ratner AJ, Bryan R, Tabibi S, Prince A (1998) Activation of NFkappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 101: 2598-2605.
22. Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB, et al. (1997) Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 100: 2810-2815.
23. Dudez T, Borot F, Huang S, Kwak BR, Bacchetta M, et al. (2008) CFTR in a lipid raft-TNFR1 complex modulates gap junctional intercellular communication and IL-8 secretion. Biochim Biophys Acta 1783: 779-788.
24. Ostedgaard LS, Rogers CS, Dong Q, Randak CO, Vermeer DW, et al. (2007) Processing and function of CFTR-DeltaF508 are species-dependent. Proc Natl Acad Sci U S A 104: 15370-15375.
25. Blackwell TS, Stecenko AA, Christman JW (2001) Dysregulated NF-kappaB activation in cystic fibrosis: evidence for a primary inflammatory disorder. Am J Physiol Lung Cell Mol Physiol 281: L69-70.
26. Stecenko AA, King G, Torii K, Breyer RM, Dworski R, et al. (2001) Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells. Inflammation 25: 145-155.
27. Venkatakrishnan A, Stecenko AA, King G, Blackwell TR, Brigham KL, et al. (2000) Exaggerated activation of nuclear factor-kappaB and altered IkappaBbeta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol 23: 396-403.
28. Srivastava M, Eidelman O, Zhang J, Paweletz C, Caohuy H, et al. (2004) Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells. Proc Natl Acad Sci U S A 101: 7693-7698.
29. Joseph T, Look D, Ferkol T (2005) NF-kappaB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 288: L471-479.
30. Weber AJ, Soong G, Bryan R, Saba S, Prince A (2001) Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Cl2 channel function. Am J Physiol Lung Cell Mol Physiol 281: L71-78.
31. Bartoszewski R, Rab A, Jurkuvenaite A, Mazur M, Wakefield J, et al. (2008) Activation of the unfolded protein response by deltaF508 CFTR. Am J Respir Cell Mol Biol 39: 448-457.
32. Bartoszewski R, Rab A, Twitty G, Stevenson L, Fortenberry J, et al. (2008) The mechanism of cystic fibrosis transmembrane conductance regulator transcriptional repression during the unfolded protein response. J Biol Chem 283: 12154-12165.
33. Rab A, Bartoszewski R, Jurkuvenaite A, Wakefield J, Collawn JF, et al. (2007) Endoplasmic reticulum stress and the unfolded protein response regulate genomic cystic fibrosis transmembrane conductance regulator expression. Am J Physiol Cell Physiol 292: C756-766.
34. Schroeder TH, Lee MM, Yacono PW, Cannon CL, Gerceker AA, et al. (2002) CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation. Proc Natl Acad Sci U S A 99: 6907-6912.
35. Schroeder TH, Reiniger N, Meluleni G, Grout M, Coleman FT, et al. (2001) Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract. J Immunol 166: 7410-7418.
36. Reiniger N, Lee MM, Coleman FT, Ray C, Golan DE, et al. (2007) Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect Immun 75: 1598-1608.
37. Collaco JM, Cutting GR (2008) Update on gene modifiers in cystic fibrosis. Curr Opin Pulm Med 14: 559-566.
38. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, et al. (2005) Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353: 1443-1453.
39. Knowles MR (2006) Gene modifiers of lung disease. Curr Opin Pulm Med 12: 416-421.
40. Kowalski MP, Pier GB (2004) Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation. J Immunol 172: 418-425.
41. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, et al. (1994) CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 10: 38-47.
42. Bruscia E, Sangiuolo F, Sinibaldi P, Goncz KK, Novelli G, et al. (2002) Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting. Gene Ther 9: 683-685.
43. Hentchel-Franks K, Lozano D, Eubanks-Tarn V, Cobb B, Fan L, et al. (2004) Activation of airway cl-secretion in human subjects by adenosine. Am J Respir Cell Mol Biol 31: 140-146.